Selection of Patients with Monoclonal Grammopathy of Undetermined Significance is Mandatory for a Reliable Use of lnterleukin-6 and Other Nonspecific Multiple Myeloma Serum Markers

C. Greco,F. Ameglio,Alvino S,Anna Maria Cianciulli,Maurizio Giovannelli,Fabrizio Mattei,Gaetano Vitelli,Irene Venturo,Massimo Lopez,Gandolfo Gm

Selection of Patients with Monoclonal Grammopathy of Undetermined Significance is Mandatory for a Reliable Use of lnterleukin-6 and Other Nonspecific Multiple Myeloma Serum Markers

1994

C. Greco
F. Ameglio
Alvino S
Anna Maria Cianciulli
Maurizio Giovannelli
Fabrizio Mattei
Gaetano Vitelli
Irene Venturo
Massimo Lopez
Gandolfo Gm

Serum levels of various immunochemical markers of clinical interest, as interleukin-6 (IL-6), C-reactive protein (CRP) and β2-microglobulin (β2M), were measured in sera from 98 s

Keywords:

Medicine
Immunology
C-reactive protein
Beta-2 microglobulin
Interleukin 6
Monoclonal gammopathy of undetermined significance
Monoclonal
Immunoglobulin G
Multiple myeloma
Immunopathology
Biomarker (medicine)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations